Skip to content

Clinical trials

Completed Hepatitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Status: Completed Clear all

203 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20019
20022
200312
20045
20053
200610
200713
20085
200917
20106
201111
201215
201317
201413
20157
20165
201710
20185
20196
20207
20217
20225
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed203

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences23
GlaxoSmithKline11
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)11
Dynavax Technologies Corporation7
National Institute of Allergy and Infectious Diseases (NIAID)7
Vir Biotechnology, Inc.5
Centers for Disease Control and Prevention4
National Heart, Lung, and Blood Institute (NHLBI)4
ViiV Healthcare4
AbbVie3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis203
Hepatitis C55
Hepatitis B37
Hepatitis C, Chronic26
Liver Diseases22
Hepatitis B, Chronic18
Fibrosis16
Hepatitis, Chronic15
Virus Diseases14
HIV Infections13

Trials

Showing 76 to 100 of 203. Each trial links to its page on Pharma Observatory.

103 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.